Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 19968507)

1.

The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals.

Cocohoba J.

Expert Rev Anti Infect Ther. 2009 Dec;7(10):1159-63. doi: 10.1586/eri.09.110.

PMID:
19968507
2.

[Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection].

Pulido Ortega F, Llenas-García J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:12-20. Review. Spanish.

PMID:
19572439
3.

[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice].

Moltó J, Clotet B.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:24-6. Review. Spanish.

PMID:
19572441
4.

[Lopinavir/ritonavir monotherapy. Possible indications].

López Aldeguer J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:21-3. Review. Spanish.

PMID:
19572440
5.

Monotherapy with lopinavir/ritonavir.

Schechter M, Nunes EP.

Expert Opin Investig Drugs. 2007 May;16(5):735-41. Review.

PMID:
17461744
6.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
7.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
8.

Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.

Sahali S, Chaix ML, Delfraissy JF, Ghosn J.

AIDS Rev. 2008 Jan-Mar;10(1):4-14. Review.

PMID:
18385776
9.

Lopinavir/ritonavir (ABT-378/r).

Qazi NA, Morlese JF, Pozniak AL.

Expert Opin Pharmacother. 2002 Mar;3(3):315-27. Review.

PMID:
11866671
10.

Lopinavir/ritonavir: appraisal of its use in HIV therapy.

von Hentig N.

Drugs Today (Barc). 2007 Apr;43(4):221-47. Review.

PMID:
17460785
11.

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.

Kaplan SS, Hicks CB.

Expert Opin Pharmacother. 2005 Aug;6(9):1573-85. Review.

PMID:
16086645
12.

Raltegravir: the first HIV integrase inhibitor.

Cocohoba J, Dong BJ.

Clin Ther. 2008 Oct;30(10):1747-65. doi: 10.1016/j.clinthera.2008.10.012. Review.

PMID:
19014832
13.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Oldfield V, Plosker GL.

Drugs. 2006;66(9):1275-99. Review.

PMID:
16827606
14.

First-line raltegravir. No evidence of comparative effectiveness.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):248-50. Review.

PMID:
21284354
15.

[Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens].

Kravchenko AV.

Ter Arkh. 2010;82(11):27-32. Review. Russian.

PMID:
21381345
16.

New therapeutic strategies for raltegravir.

Garrido C, Soriano V, de Mendoza C.

J Antimicrob Chemother. 2010 Feb;65(2):218-23. doi: 10.1093/jac/dkp447. Epub 2009 Dec 16. Review.

17.

The use of integrase inhibitors in treatment-experienced patients.

Gatell JM.

Eur J Med Res. 2009 Nov 24;14 Suppl 3:30-5. Review.

18.

Elevated liver enzymes resulting from an interaction between Raltegravir and Panax ginseng: a case report and brief review.

Mateo-Carrasco H, Gálvez-Contreras MC, Fernández-Ginés FD, Nguyen TV.

Drug Metabol Drug Interact. 2012;27(3):171-5. doi: 10.1515/dmdi-2012-0019. Review.

PMID:
23092794
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk